Rankings
▼
Calendar
NAUT Q4 2023 Earnings — Nautilus Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
NAUT
Nautilus Biotechnology, Inc.
$339M
Q4 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$2M
Operating Income
-$20M
Net Income
-$17M
EPS (Diluted)
$-0.14
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$14M
Free Cash Flow
-$14M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$306M
Total Liabilities
$40M
Stockholders' Equity
$265M
Cash & Equivalents
$19M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$2M
-$921,000
-72.6%
Operating Income
-$20M
-$16M
-22.7%
Net Income
-$17M
-$13M
-27.0%
← FY 2023
All Quarters
Q1 2024 →